HealthStream's Q3 Revenue Climbs, Net Income Up 4.6% Amid Share Buybacks

TL;DR

**HSTM is a steady performer with growing subscription revenue, but watch those share buybacks eating into cash.**

AI Summary

HealthStream, Inc. (HSTM) reported a robust financial performance for the nine months ended September 30, 2025, with net revenues increasing to $224.355 million, up 3.2% from $217.411 million in the prior year. Net income also saw a healthy rise, reaching $15.808 million, a 4.6% increase from $15.118 million in the same period of 2024. The company's core subscription services revenue grew to $216.617 million, up from $209.136 million, demonstrating strong demand for its SaaS-based healthcare applications. Operating income improved to $17.832 million for the nine months, compared to $16.598 million in 2024. Cash and cash equivalents decreased to $53.544 million from $59.469 million at the beginning of the period, primarily due to significant common stock repurchases totaling $25.018 million. The company also increased its dividend declared per share to $0.031 from $0.028 in the prior year, reflecting confidence in future earnings. Capitalized software development, a key investment in its hStream platform, increased to $45.699 million from $43.370 million at December 31, 2024, indicating continued product innovation. Total assets slightly decreased to $499.930 million from $510.766 million, while total shareholders' equity declined to $349.193 million from $359.355 million, largely influenced by the share repurchases.

Why It Matters

HealthStream's consistent revenue growth in subscription services, up 3.6% to $216.617 million, signals strong demand for its healthcare SaaS solutions, which is crucial for investors seeking stable, recurring revenue streams in the competitive health tech sector. The company's strategic investment in its hStream technology platform, evidenced by increased capitalized software development, positions it for future innovation and competitive advantage against rivals like Relias and UKG. However, the substantial $25.018 million in common stock repurchases, while potentially boosting EPS, also contributed to a decrease in cash and cash equivalents, which could impact future liquidity or investment capacity. Employees and customers benefit from the continued development of the hStream platform, promising enhanced tools for learning, clinical development, and scheduling in healthcare.

Risk Assessment

Risk Level: medium — The company's cash and cash equivalents decreased by $5.925 million for the nine months ended September 30, 2025, primarily due to $25.018 million in common stock repurchases. While operating activities generated $50.127 million in cash, significant outflows for share repurchases and capitalized software development ($21.910 million) could limit financial flexibility for future strategic investments or acquisitions if not managed carefully.

Analyst Insight

Investors should monitor HealthStream's cash flow and capital allocation strategy closely, particularly the balance between share repurchases and investments in product development. While the subscription revenue growth is positive, a continued aggressive share repurchase program could strain liquidity. Consider HSTM for long-term growth in healthcare SaaS, but be aware of potential short-term cash pressures.

Financial Highlights

debt To Equity

N/A

revenue

$224.355M

operating Margin

7.95%

total Assets

$499.930M

total Debt

N/A

net Income

$15.808M

eps

$0.52

gross Margin

N/A

cash Position

$53.544M

revenue Growth

+3.2%

Revenue Breakdown

Key Numbers

• $224.355M — Total Revenues (Increased from $217.411M in 2024, a 3.2% rise for the nine months ended Sep 30, 2025.)
• $15.808M — Net Income (Increased from $15.118M in 2024, a 4.6% rise for the nine months ended Sep 30, 2025.)
• $216.617M — Subscription Services Revenue (Increased from $209.136M in 2024, showing strong core business growth.)
• $25.018M — Common Stock Repurchases (Significant cash outflow for the nine months ended Sep 30, 2025, impacting cash balance.)
• $53.544M — Cash and Cash Equivalents (Decreased from $59.469M at Dec 31, 2024, partly due to share repurchases.)
• $0.20 — Diluted Net Income Per Share (Increased from $0.19 in Q3 2024, indicating improved profitability per share.)
• $0.031 — Dividends Declared Per Share (Increased from $0.028 in Q3 2024, reflecting shareholder returns.)
• $45.699M — Capitalized Software Development, net (Increased from $43.370M at Dec 31, 2024, showing investment in product innovation.)
• $50.127M — Net Cash Provided by Operating Activities (Increased from $46.500M in 2024, demonstrating strong operational cash generation.)
• 29,668,137 — Shares Outstanding (As of November 3, 2025, reduced from 30,432,000 at Dec 31, 2024 due to repurchases.)

Key Players & Entities

• HealthStream, Inc. (company) — Registrant and provider of SaaS-based applications for healthcare organizations
• hStream (company) — Proprietary technology platform at the center of HealthStream's approach
• FASB (regulator) — Financial Accounting Standards Board, issuer of accounting standards updates
• $224.355 million (dollar_amount) — Total revenues for the nine months ended September 30, 2025
• $15.808 million (dollar_amount) — Net income for the nine months ended September 30, 2025
• $216.617 million (dollar_amount) — Subscription services revenue for the nine months ended September 30, 2025
• $25.018 million (dollar_amount) — Repurchases of common stock for the nine months ended September 30, 2025
• $53.544 million (dollar_amount) — Cash and cash equivalents at September 30, 2025
• $0.031 (dollar_amount) — Dividends declared per share for the three months ended September 30, 2025
• Nasdaq Global Select Market (regulator) — Exchange where HealthStream's common stock is registered

FAQ

Risk Factors

• Intense Competition [medium — market]: The healthcare IT market is highly competitive, with numerous companies offering similar solutions. This intense competition could pressure pricing and market share, impacting revenue growth and profitability.
• Data Privacy and Security [high — regulatory]: Handling sensitive patient data makes HealthStream subject to stringent data privacy regulations like HIPAA. Breaches or non-compliance could lead to significant fines, reputational damage, and legal liabilities.
• Dependence on Technology [medium — operational]: The company's SaaS model relies heavily on its technology infrastructure. Any disruptions, system failures, or cybersecurity threats could impact service delivery and customer satisfaction.
• Share Repurchases Impact [low — financial]: Significant common stock repurchases totaling $25.018 million for the nine months ended September 30, 2025, reduced cash and cash equivalents from $59.469 million to $53.544 million. While signaling confidence, this outflow impacts liquidity.
• Customer Concentration [medium — market]: While not explicitly detailed in the summary, reliance on a few large healthcare systems for a significant portion of revenue could pose a risk if those clients are lost or reduce their spending.
• Product Development and Innovation [medium — operational]: Continued investment in capitalized software development, increasing to $45.699 million, is crucial. Failure to innovate or adapt to evolving healthcare needs could lead to obsolescence.
• Changes in Healthcare Regulations [medium — regulatory]: Evolving healthcare policies and reimbursement models can impact the demand for HealthStream's solutions. Changes in government regulations could affect customer budgets and adoption rates.
• Intangible Asset Impairment [low — financial]: The company holds significant goodwill ($191.623 million) and intangibles ($45.369 million). Adverse business conditions or changes in valuation could lead to impairment charges, impacting net income.

Industry Context

The healthcare IT sector is characterized by rapid technological advancements and a growing demand for solutions that improve patient care, operational efficiency, and regulatory compliance. Key trends include the adoption of cloud-based solutions (SaaS), data analytics for insights, and enhanced cybersecurity measures. HealthStream operates in this dynamic environment, competing with established players and emerging innovators.

Regulatory Implications

HealthStream's operations are subject to significant regulatory oversight, particularly concerning data privacy (HIPAA) and healthcare compliance. Changes in government healthcare policies, reimbursement models, and data security mandates can directly impact the company's product offerings, customer demand, and operational costs. Maintaining robust compliance programs is critical to mitigate risks of fines and reputational damage.

What Investors Should Do

1. Monitor subscription revenue growth closely.
2. Evaluate the impact of share repurchases on liquidity and future growth investments.
3. Assess the company's investment in product innovation.
4. Review the company's risk factor disclosures for evolving threats.

Key Dates

• 2025-09-30: Nine Months Ended — Reporting period for the 10-Q, showing revenue growth of 3.2% and net income increase of 4.6%.
• 2025-11-03: Shares Outstanding — As of this date, shares outstanding were 29,668,137, down from 30,432,000 at year-end 2024 due to repurchases.
• 2024-12-31: Year-End — Prior period balance sheet figures for comparison, showing cash and cash equivalents of $59.469 million and total assets of $510.766 million.

Glossary

Capitalized software development, net

Costs incurred in developing software that are capitalized on the balance sheet rather than expensed immediately, reflecting investment in future product capabilities. (Increased to $45.699 million, indicating ongoing investment in HealthStream's hStream platform and product innovation.)

Common stock repurchases

The company buying back its own shares from the open market, reducing the number of outstanding shares and potentially increasing earnings per share. (Totaled $25.018 million for the nine months, impacting cash levels but also signaling management's confidence and commitment to shareholder value.)

Deferred revenue

Revenue that has been received by the company but not yet earned, typically from subscription services paid in advance. (Total current deferred revenue was $85.687 million, a significant portion of current liabilities, reflecting the recurring nature of HealthStream's business model.)

Goodwill

An intangible asset that arises when a company acquires another company for a price greater than the fair value of its identifiable net assets. (Stands at $191.623 million, representing a substantial portion of total assets, indicating past acquisitions.)

Operating lease right of use assets, net

Assets recognized on the balance sheet representing the right to use an asset for the lease term, typically for property or equipment. (Decreased to $15.667 million, reflecting the amortization of these assets over their lease terms.)

SaaS

Software as a Service, a software distribution model where a third-party provider hosts applications and makes them available to customers over the Internet. (HealthStream's core subscription services revenue of $216.617 million is derived from its SaaS-based healthcare applications, demonstrating the strength of this model.)

hStream platform

HealthStream's proprietary technology platform that underpins its various healthcare applications and services. (Continued investment in capitalized software development for this platform highlights its strategic importance for future growth and innovation.)

Diluted Net Income Per Share

The net income for the period divided by the weighted-average number of common shares outstanding, including the dilutive effect of stock options and other potential common shares. (Reported at $0.50 for the nine months ended September 30, 2025, an increase from $0.50 in the prior year, indicating improved profitability on a per-share basis.)

Year-Over-Year Comparison

Compared to the prior year's nine-month period, HealthStream has demonstrated solid top-line growth, with net revenues increasing by 3.2% to $224.355 million. Net income also saw a healthy rise of 4.6% to $15.808 million. While cash reserves have decreased due to significant share repurchases ($25.018 million), operating cash flow remains strong, increasing to $50.127 million. The company continues to invest in its future, evidenced by the rise in capitalized software development.

Key Financial Figures

• $0.00 — ch registered Common Stock (Par Value $0.00) HSTM Nasdaq Global Select Market

Filing Documents

• hstm20250930_10q.htm (10-Q) — 914KB
• ex_854732.htm (EX-31.1) — 9KB
• ex_854733.htm (EX-31.2) — 9KB
• ex_854734.htm (EX-32.1) — 5KB
• ex_854735.htm (EX-32.2) — 5KB
• 0001437749-25-033632.txt ( ) — 4268KB
• hstm-20250930.xsd (EX-101.SCH) — 32KB
• hstm-20250930_cal.xml (EX-101.CAL) — 36KB
• hstm-20250930_def.xml (EX-101.DEF) — 246KB
• hstm-20250930_lab.xml (EX-101.LAB) — 242KB
• hstm-20250930_pre.xml (EX-101.PRE) — 271KB
• hstm20250930_10q_htm.xml (XML) — 525KB

Financial Statements

Financial Statements 1 Condensed Consolidated Balance Sheets (Unaudited) – September 30, 2025 and December 31, 2024 1 Condensed Consolidated Statements of Income (Unaudited) – Three and Nine Months ended September 30, 2025 and 2024 2 Condensed Consolidated Statements of Comprehensive Income (Unaudited) – Three and Nine Months ended September 30, 2025 and 2024 3 Condensed Consolidated Statement of Shareholders' Equity (Unaudited) – Three and Nine Months ended September 30, 2025 and 2024 4 Condensed Consolidated Statements of Cash Flows (Unaudited) – Nine Months ended September 30, 2025 and 2024 5 Notes to Condensed Consolidated Financial Statements (Unaudited) 6 Item 2.

Management's Discussion and Analysis of Financial Condition and Results of Operations

Management's Discussion and Analysis of Financial Condition and Results of Operations 12 Item 3.

Quantitative and Qualitative Disclosures about Market Risk

Quantitative and Qualitative Disclosures about Market Risk 18 Item 4.

Controls and Procedures

Controls and Procedures 18 Part II. Other Information 19 Item 1.

Legal Proceedings

Legal Proceedings 19 Item 1A.

Risk Factors

Risk Factors 19 Item 2. Unregistered Sales of Equity Securities and Use of Proceeds 20 Item 5. Other Information 20 Item 6. Exhibits 21 SIGNATURE 22 Table of Contents

FINANCIAL INFORMATION

PART I. FINANCIAL INFORMATION

Financial Statements

Item 1. Financial Statements HEALTHSTREAM, INC. CONDENSED CONSOLIDATED BALANCE SHEETS (UNAUDITED) (In thousands) September 30, December 31, 2025 2024 ASSETS Current assets: Cash and cash equivalents $ 53,544 $ 59,469 Marketable securities 39,047 37,748 Accounts receivable, net 27,675 30,189 Accounts receivable - unbilled 6,047 5,133 Prepaid and other current assets 21,261 20,583 Total current assets 147,574 153,122 Property and equipment, net 11,143 10,741 Capitalized software development, net 45,699 43,370 Operating lease right of use assets, net 15,667 17,453 Goodwill 191,623 191,220 Intangibles, net 45,369 55,548 Other assets 42,855 39,312 Total assets $ 499,930 $ 510,766 LIABILITIES AND SHAREHOLDERS' EQUITY Current liabilities: Accounts payable $ 3,924 $ 6,628 Accrued royalties 5,642 5,190 Accrued liabilities 10,643 10,141 Accrued compensation 6,600 9,507 Deferred revenue 85,687 84,227 Total current liabilities 112,496 115,693 Deferred tax liabilities 19,671 14,596 Deferred revenue, noncurrent 1,289 1,655 Operating lease liability, noncurrent 15,292 17,366 Other long-term liabilities 1,989 2,101 Commitments and contingencies Shareholders' equity: Preferred Stock, no par value, 10,000 shares authorized, no shares issued or outstanding — — Common stock, no par value, 75,000 shares authorized; 29,652 and 30,432 shares issued and outstanding at September 30, 2025 and December 31, 2024, respectively 228,753 252,432 Retained earnings 121,972 108,972 Accumulated other comprehensive loss ( 1,532 ) ( 2,049 ) Total shareholders' equity 349,193 359,355 Total liabilities and shareholders' equity $ 499,930 $ 510,766 See accompanying Notes to the unaudited Condensed Consolidated Financial Statements. 1 Table of Contents HEALTHSTREAM, INC. CONDENSED CONSOLIDATED STATEMENTS OF INCOME (UNAUDITED) (In thousands, except per share data) Three Months Ended Nine

View Full Filing

View this 10-Q filing on SEC EDGAR